Tissue Repair Ltd (TRP) - Total Assets
Based on the latest financial reports, Tissue Repair Ltd (TRP) holds total assets worth AU$14.57 Million AUD (≈ $10.31 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Tissue Repair Ltd for net asset value and shareholders' equity analysis.
Tissue Repair Ltd - Total Assets Trend (2020–2025)
This chart illustrates how Tissue Repair Ltd's total assets have evolved over time, based on quarterly financial data.
Tissue Repair Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Tissue Repair Ltd's total assets of AU$14.57 Million consist of 97.8% current assets and 2.2% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 84.5% |
| Accounts Receivable | AU$1.74 Million | 11.9% |
| Inventory | AU$392.00 | 0.0% |
| Property, Plant & Equipment | AU$321.29K | 2.2% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Tissue Repair Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Tissue Repair Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tissue Repair Ltd's current assets represent 97.8% of total assets in 2025, a decrease from 99.6% in 2020.
- Cash Position: Cash and equivalents constituted 84.5% of total assets in 2025, down from 86.3% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 11.9% of total assets.
Tissue Repair Ltd Competitors by Total Assets
Key competitors of Tissue Repair Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
Ascendis Pharma AS
F:A71
|
Germany | €1.30 Billion |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076
|
China | CN¥6.69 Billion |
|
Wuhan Keqian Biology Co Ltd
SHG:688526
|
China | CN¥4.75 Billion |
|
R&G PharmaStudies Co. Ltd. A
SHE:301333
|
China | CN¥2.31 Billion |
|
Shanghai Shen Lian Biomedical Corp
SHG:688098
|
China | CN¥1.56 Billion |
Tissue Repair Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 22.40 | 14.50 | 4.02 |
| Quick Ratio | 22.40 | 14.34 | 4.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$13.62 Million | AU$18.05 Million | AU$994.90K |
Tissue Repair Ltd - Advanced Valuation Insights
This section examines the relationship between Tissue Repair Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.78 |
| Latest Market Cap to Assets Ratio | 0.40 |
| Asset Growth Rate (YoY) | -24.8% |
| Total Assets | AU$14.57 Million |
| Market Capitalization | $5.78 Million USD |
Valuation Analysis
Below Book Valuation: The market values Tissue Repair Ltd's assets below their book value (0.40x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Tissue Repair Ltd's assets decreased by 24.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Tissue Repair Ltd (2020–2025)
The table below shows the annual total assets of Tissue Repair Ltd from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$14.57 Million ≈ $10.31 Million |
-24.84% |
| 2024-06-30 | AU$19.39 Million ≈ $13.72 Million |
-13.36% |
| 2023-06-30 | AU$22.38 Million ≈ $15.83 Million |
-13.59% |
| 2022-06-30 | AU$25.90 Million ≈ $18.32 Million |
-6.20% |
| 2021-06-30 | AU$27.61 Million ≈ $19.54 Million |
+1977.40% |
| 2020-06-30 | AU$1.33 Million ≈ $940.36K |
-- |
About Tissue Repair Ltd
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical … Read more